Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   MYLAN
EQUITY SHARE DATA
    LUPIN
Mar-23
MYLAN
Dec-18
LUPIN/
MYLAN
5-Yr Chart
Click to enlarge
High Rs7993,967-   
Low Rs5832,184-   
Sales per share (Unadj.) Rs365.81,825.4-  
Earnings per share (Unadj.) Rs9.849.6-  
Cash flow per share (Unadj.) Rs29.2391.3-  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs270.71,974.7-  
Shares outstanding (eoy) m454.98514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.7 112.1%   
Avg P/E ratio x70.262.0 113.2%  
P/CF ratio (eoy) x23.77.9 301.2%  
Price / Book Value ratio x2.61.6 163.9%  
Dividend payout %40.70-   
Avg Mkt Cap Rs m314,3811,582,214 19.9%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m30,8720-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m166,417939,158 17.7%  
Other income Rs m1,5090-   
Total revenues Rs m167,926939,158 17.9%   
Gross profit Rs m17,206243,019 7.1%  
Depreciation Rs m8,807175,847 5.0%   
Interest Rs m2,74345,170 6.1%   
Profit before tax Rs m7,16522,002 32.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688-3,500 -76.8%   
Profit after tax Rs m4,47725,502 17.6%  
Gross profit margin %10.325.9 40.0%  
Effective tax rate %37.5-15.9 -235.8%   
Net profit margin %2.72.7 99.1%  
BALANCE SHEET DATA
Current assets Rs m124,513524,425 23.7%   
Current liabilities Rs m92,654382,364 24.2%   
Net working cap to sales %19.115.1 126.6%  
Current ratio x1.31.4 98.0%  
Inventory Days Days2684 31.4%  
Debtors Days Days9893 105.3%  
Net fixed assets Rs m103,490182,181 56.8%   
Share capital Rs m910500 182.0%   
"Free" reserves Rs m122,2460-   
Net worth Rs m123,1561,015,998 12.1%   
Long term debt Rs m2751,096,588 0.0%   
Total assets Rs m228,0032,725,301 8.4%  
Interest coverage x3.61.5 242.9%   
Debt to equity ratio x01.1 0.2%  
Sales to assets ratio x0.70.3 211.8%   
Return on assets %3.22.6 122.1%  
Return on equity %3.62.5 144.8%  
Return on capital %8.03.2 252.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m26,3060-   
CASH FLOW
From Operations Rs m18,972195,157 9.7%  
From Investments Rs m-12,868-100,875 12.8%  
From Financial Activity Rs m-3,373-90,916 3.7%  
Net Cashflow Rs m2,7321,617 169.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare LUPIN With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare LUPIN With: BHARAT PARENTALS  WINDLAS BIOTECH  SMS PHARMA  ALPA LAB  DENIS CHEM LAB  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.